CURTIS R PICKERING to Antineoplastic Combined Chemotherapy Protocols
This is a "connection" page, showing publications CURTIS R PICKERING has written about Antineoplastic Combined Chemotherapy Protocols.
Connection Strength
0.101
-
Bcl-2 inhibition or FBXW7 mutation sensitizes solid tumor cells to HDAC inhibition in vitro but could prove difficult to validate in patients. Cancer Discov. 2013 Mar; 3(3):258-9.
Score: 0.095
-
Chk1/2 inhibition overcomes the cisplatin resistance of head and neck cancer cells secondary to the loss of functional p53. Mol Cancer Ther. 2013 Sep; 12(9):1860-73.
Score: 0.006